Published on Spencer Knight via LinkedIn Neurona Therapeutics has secured $102 million to push forward its cell therapy NRTX-1001, which...

Published on Spencer Knight via LinkedIn Atsena Therapeutics has secured an oversubscribed $150 million Series C round, led by Bain...

Published on Spencer Knight via LinkedIn Multiple gene editing breakthroughs were announced in a single week, signaling strong momentum...

Published on Spencer Knight via LinkedIn Concerns about secondary cancers from CAR-T therapy may be overstated, according to new data. A...

Published on Spencer Knight via LinkedIn A 14-month-old boy named Tomas, born with a life-threatening liver disorder called OTC...

Published on Spencer Knight via LinkedIn AstraZeneca has acquired Belgian biotech EsoBiotec for $1 billion, including $425 million...

Published on Spencer Knight via LinkedIn Bristol Myers Squibb has acquired 2seventy bio in an all-cash deal worth $286 million, offering...

Published on Spencer Knight via LinkedIn CAR T-cell therapy has revolutionized oncology, but its next frontier is outside of cancer...

Published on Spencer Knight via LinkedIn There are more than 300 million people worldwide living with rare diseases, many of them with no...

Published on Spencer Knight via LinkedIn Regeneron has announced a major milestone in pediatric gene therapy using its DB-OTO treatment....

Published on Spencer Knight via LinkedIn A gene therapy trial at Moorfields Eye Hospital in London has given four children born with...

Published on Spencer Knight via LinkedIn Between 2004 - 2009, 19 children with neuroblastoma joined a CAR-T clinical trial at Baylor...

Published on Spencer Knight via LinkedIn Spencer Knight shares a compelling visual breakdown of 187 gene editing companies across four...

Published on Spencer Knight via LinkedIn 21-year-old Sebastien Beauzile spent his life in constant pain from sickle cell disease, unable...

Published on Spencer Knight via LinkedIn CAR-T once promised a revolution, then came the cost, complexity, and clinical setbacks. Spencer...

Published on Spencer Knight via LinkedIn Sana Biotechnology has announced successful first-in-human results using HIP-engineered islet...

Published on Repligen Poster, Bioprocessing Summit (July 2023) With biologics becoming more complex and global manufacturing capacity...

Published on Repligen White Paper (July 2022) Facing growing demand for veterinary vaccines, MSD Animal Health partnered with Repligen to...

Published on Repligen Application Note (Sept 2024) Lentiviral vector production is a major bottleneck in CAR-T manufacturing, but...

Published on Repligen Scientific Poster (Sept 2022) To meet growing demand in gene therapy, Repligen scientists applied tangential flow...